Exchange Traded Concepts’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$619K Sell
17,509
-262
-1% -$10.7K ﹤0.01% 965
2025
Q4
$722K Buy
17,771
+6,350
+56% +$276K 0.01% 932
2025
Q3
$537K Buy
11,421
+1,489
+15% +$77.2K ﹤0.01% 995
2025
Q2
$517K Buy
9,932
+231
+2% +$12.7K 0.01% 900
2025
Q1
$586K Buy
9,701
+217
+2% +$14K 0.01% 763
2024
Q4
$649K Buy
9,484
+139
+1% +$9.69K 0.01% 741
2024
Q3
$672K Buy
9,345
+333
+4% +$23.5K 0.02% 704
2024
Q2
$625K Buy
9,012
+100
+1% +$7.29K 0.02% 631
2024
Q1
$714K Buy
8,912
+2,651
+42% +$236K 0.02% 507
2023
Q4
$686K Sell
6,261
-1,414
-18% -$146K 0.02% 491
2023
Q3
$774K Sell
7,675
-183
-2% -$21K 0.02% 442
2023
Q2
$1.07M Sell
7,858
-2,537
-24% -$310K 0.03% 378
2023
Q1
$1.08M Sell
10,395
-1,465
-12% -$142K 0.03% 317
2022
Q4
$1.05M Buy
11,860
+141
+1% +$11.7K 0.03% 303
2022
Q3
$940K Buy
11,719
+1,986
+20% +$187K 0.03% 281
2022
Q2
$932K Buy
9,733
+73
+0.8% +$8.76K 0.03% 302
2022
Q1
$1.44M Sell
9,660
-3,790
-28% -$529K 0.03% 266
2021
Q4
$1.91M Sell
13,450
-3,746
-22% -$531K 0.04% 243
2021
Q3
$2.25M Buy
17,196
+2,350
+16% +$307K 0.06% 217
2021
Q2
$2.04M Buy
14,846
+47
+0.3% +$6.43K 0.06% 221
2021
Q1
$1.93M Buy
14,799
+4,261
+40% +$513K 0.07% 208
2020
Q4
$1.18M Buy
10,538
+5,647
+115% +$535K 0.05% 206
2020
Q3
$385K Buy
4,891
+2,037
+71% +$166K 0.02% 360
2020
Q2
$205K Buy
2,854
+1,794
+169% +$125K 0.03% 470
2020
Q1
$61K Buy
1,060
+544
+105% +$50.2K 0.03% 284
2019
Q4
$58K Buy
+516
New +$55K 0.01% 263

Other funds holding CNMD

Exchange Traded Concepts's CNMD Position: Q1 2026 in Review

Exchange Traded Concepts reduced its CONMED (CNMD) stake by 1.5% in Q1 2026, selling an estimated $10.7K and leaving 17,509 shares worth $619K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

Exchange Traded Concepts first reported a position in CNMD in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.25M in Q3 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Exchange Traded Concepts held 17,509 shares of CONMED worth $619K as of Q1 2026.
  • Exchange Traded Concepts sold 262 CONMED shares in Q1 2026, an estimated $10.7K.
  • CONMED made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q1 2026, its #965 holding.
  • Exchange Traded Concepts first reported a position in CONMED in Q4 2019 and has held it in 26 quarters since.
  • Exchange Traded Concepts's CONMED position peaked at $2.25M in Q3 2021.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.